Bharat Biotech is fasting the trial phases of the COVID vaccine because the active cases are increasing continuously in India. Moreover, the death rate is also fastening in the nation of India. Bharat Biotech has said that this vaccine is having chances to pass the human phase trail also because it has successfully cleared out the animal trail. Ergo, it has been noted that there are no adverse effects of this drug found by the Bharat Biotech Limited Company. People are hoping for the best thing to happen because the pandemic of the COVID virus has made the life of people hell.
HIGHLIGHTS:
- PGI in the state of Haryana is one of the twelve institutes that has been selected for the vaccine trial of COVID-19.
- The trails of Phase 1 and 2 are going to be completed in the upcoming 15 months.
Recently, we got information that Bharat Biotech has started the trails of the COVID vaccine on Humans, Covaxin is the name of vaccine that has been designed to fight against the pandemic outbreak of the novel coronavirus. Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS) on Friday tweeted that they have already started the vaccine trials at their place in Rohtak, Haryana. Ergo, this information was claimed after the tweets from state health minister Anil Vij.
PGIMS is one of the twelve institutes that was chosen for 125 participant trail of the vaccine candidate which is jointly developed after the research of Bharat Biotech Company and ICMR (Indian Council of Medical Research). This joint research from Biotech and ICMR has also claimed that the vaccine trial is on priority need and hopefully it is going to launch as soon as possible. However, according to the letter, the time needed for phase 1 and 2 trials of vaccine is around 15 to 12 months but still, the company claimed that the vaccine will be developed in the upcoming month.
Probing further, but now from the recent updates, it has been found the company is backtracking from the deadline and justified that the letter leaked out was only meant to expedite the trial by removing red tapes. ICMR (Indian Council of Medical Research) and Biotech have refused to comment on this matter, let’s cross our fingers and wait for a miracle to happen.
Ergo, stay connected to have more details about the COVID vaccine.
